The goal of this project is to examine the causes of racial and gender differences in the treatment of elderly patients with coronary artery disease and heart failure.
The term "medical necessity" is used in insurance contracts to refer to medical services that are generally recognized as appropriate for the diagnosis, prevention, or treatment of disease and injury. Although insurers have a contractual obligation to reimburse patients for these services, there is no consensus on how to define and apply the term.
Cubberly Auditorium, School of Education, Stanford University
Professor Joshua Lederberg, a research geneticist, is Sackler Foundation Scholar, President-emeritus at The Rockefeller University in New York, and a consulting professor of the Institute for International Studies at Stanford University. Dr. Lederberg was educated at Columbia and Yale University, where he pioneered in the field of bacterial genetics with the discovery of genetic recombination in bacteria. In 1958, at the age of 33, Dr. Lederberg received the Nobel Prize in Physiology of Medicine for this work. Dr. Lederberg has been a professor of genetics at the University of Wisconsin and then at Stanford University School of Medicine, until he came to The Rockefeller University in 1978. A member of the National Academy of Sciences since 1957, and a charter member of its Institute of Medicine, Dr. Lederberg has been active in many government advisory roles, including the Defense Science Board and the Chair of the President's Cancer Panel. He has long had a keen interest in international health, and has served two terms on WHO's Advisory Health Research Council and on the boards of the Center for Strategic and International Studies (Washington) and the Council on Foreign Relations (New York). He co-chaired the IOM's study on Emerging Infections, and recently edited "Biological Weapons: Containing the Threat", published by the MIT Press.
Bechtel Center, Encina Hall
Approximately 13 speakers will be presenting throughout the day. For a detailed schedule please contact Robin Holbrook, 650-723-6270
Fairchild Auditorium
The TECH project is an international collaboration aimed at understanding patterns of technology adoption and diffusion of medical care and the effects of these patterns on patient outcomes. The team, organized from 17 developed countries, is exploring whether individuals living in countries that rapidly adopted new revascularization technologies and clot-dissolving drugs are more likely to survive heart attacks than individuals living in countries that have adopted such interventions more slowly.
The TECH project has three specific goals:
The Comparative Health Care Policy Research Project was initiated by APARC in 1990 to examine issues related to the structure and delivery of health care in Japan by utilizing contemporary social science. Further, the project was designed to make the study of Japan an integral part of international comparative health policy research. Yumiko Nishimura, the associate director, under the supervision of Daniel I. Okimoto, the principal investigator, leads the project.
Grant Building, Room S156
Stanford, California 94305-5107